Skip to main content

Correction: Dyslipidemia and metabolic syndrome in childhood-onset systemic lupus erythematosus: is it time to screen?

The Original Article was published on 18 December 2024

Correction: Lipids in Health and Disease 23, 406 (2024)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-024-02395-4

Following publication of the original article [1], the authors requested to update the Methods section.

In the methods section regarding the definition of metabolic syndrome on page 3, the sentences currently reads:

“Metabolic syndrome” was defined according to International Diabetes Federation criteria, which diagnose patients aged at least 10 years; the definition of metabolic syndrome in children and adolescents age 10 to less than 16 years were obesity ≥ 90th percentile (or adult cutoff if lower) as assessed by waist circumference, TG ≥ 150 mg/dL (1.7 mmol/L), HDL-C < 40 mg/dL (1.03 mmol/L), systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg, FBG ≥ 100 mg/dL (5.6 mmol/L) or known type 2 diabetes mellitus [33]; for age 16 years or older, the adult definition for metabolic syndrome definition were applied consisting of waist circumference ≥ 90 cm for men or ≥ 80 cm for women, plus any two of the following: raised TG > 150 mg/dL (1.7 mmol/L) or specific treatment for this lipid abnormality, reduced HDL-C < 40 mg/dl (1.03 mmol/L) in men or < 50 mg/L (1.29 mmol/L) in women or specific treatment for this lipid abnormality, raised systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or treatment of previously diagnosed hypertension, raised FBG ≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed type 2 diabetes mellitus [17, 33].

The sentence should read:

“Metabolic syndrome” was defined according to International Diabetes Federation criteria, which diagnose patients aged at least 10 years; the definition of metabolic syndrome in children and adolescents age 10 to less than 16 years were obesity ≥ 90th percentile (or adult cutoff if lower) as assessed by waist circumference, plus any two of the following: TG ≥ 150 mg/dL (1.7 mmol/L), HDL-C < 40 mg/dL (1.03 mmol/L), systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg, FBG ≥ 100 mg/dL (5.6 mmol/L) or known type 2 diabetes mellitus [33]; for age 16 years or older, the adult definition for metabolic syndrome definition were applied consisting of waist circumference ≥ 90 cm for men or ≥ 80 cm for women, plus any two of the following: raised TG  150 mg/dL (1.7 mmol/L) or specific treatment for this lipid abnormality, reduced HDL-C < 40 mg/dl (1.03 mmol/L) in men or < 50 mg/L (1.29 mmol/L) in women or specific treatment for this lipid abnormality, raised systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or treatment of previously diagnosed hypertension, raised FBG ≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed type 2 diabetes mellitus [17, 33].

In the methods section regarding the sample size calculation on page 4, the sentences currently reads:

The parameters used were type I error (α) = 0.05, allowable error (e) = 0.0945 (15% of p), Zɑ/2 = Z0.025 = 1.96, and p = 0.63. This calculation resulted in a minimum sample size of 100 participants. Accounting for a 10% dropout rate, the final sample size for this study was determined to be at least 111 participants.

The sentence should read.

The parameters used were type I error (α) = 0.05, allowable error (e) = 0.07 (12% of p), Zɑ/2 = Z0.025 = 1.96, and p = 0.63. This calculation resulted in a minimum sample size of 182 participants. Accounting for a 10% dropout rate, the final sample size for this study was determined to be 200 participants.

The original article [1] has been corrected.

References

  1. Nuntasri S, Charuvanij S, Lomjansook K, et al. Dyslipidemia and metabolic syndrome in childhood-onset systemic lupus erythematosus: is it time to screen? Lipids Health Dis. 2024;23:406. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-024-02395-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maynart Sukharomana.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-024-02395-4.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nuntasri, S., Charuvanij, S., Lomjansook, K. et al. Correction: Dyslipidemia and metabolic syndrome in childhood-onset systemic lupus erythematosus: is it time to screen?. Lipids Health Dis 24, 34 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-025-02453-5

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-025-02453-5